Stroke, Vol 21, 1589-1593, Copyright © 1990 by American Heart Association
PD Lyden, KP Madden, WM Clark, KC Sasse and JA Zivin
We studied thrombolysis in an animal model of embolic stroke to determine
the safety of tissue plasminogen activator and streptokinase. We occluded
the middle cerebral arteries of 137 rabbits with radiolabeled blood clots
and administered tissue plasminogen activator (n = 49), streptokinase (n =
40), or saline (n = 48) at various times after embolization. We assessed
the rate of thrombolysis and cerebral hemorrhage 24 hours later. Both drugs
were very effective in producing thrombolysis. Compared with saline,
streptokinase caused a significant increase in the rate of cerebral
hemorrhage (p less than 0.05), but tissue plasminogen activator did not. We
conclude that thrombolytic therapy for acute stroke should be safer with
tissue plasminogen activator than with streptokinase.
ARTICLES
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected] [published erratum appears in Stroke 1991 Feb;22(2):285]
Department of Neurology, Veterans Administration Medical Center, San Diego, CA 92161.
This article has been cited by other articles:
![]() |
P. A. Lapchak, M.-K. Han, K. F. Salgado, J. Streeter, and J. A. Zivin Safety Profile of Transcranial Near-Infrared Laser Therapy Administered in Combination With Thrombolytic Therapy to Embolized Rabbits Stroke, November 1, 2008; 39(11): 3073 - 3078. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jahan, D. Stewart, H. V. Vinters, W. Yong, F. Vinuela, P. Vandeberg, and V. J. Marder Middle Cerebral Artery Occlusion in the Rabbit Using Selective Angiography: Application for Assessment of Thrombolysis Stroke, May 1, 2008; 39(5): 1613 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lapchak, D. M. Araujo, D. Song, and J. A. Zivin The Nonpeptide Glycoprotein IIb/IIIa Platelet Receptor Antagonist SM-20302 Reduces Tissue Plasminogen Activator-Induced Intracerebral Hemorrhage After Thromboembolic Stroke Stroke, January 1, 2002; 33(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Chapman, P. Lyden, P. A. Lapchak, S. Nunez, H. Thibodeaux, and J. Zivin Comparison of TNK With Wild-Type Tissue Plasminogen Activator in a Rabbit Embolic Stroke Model Stroke, March 1, 2001; 32(3): 748 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
A C Pereira, P J Martin, and E A Warburton Thrombolysis in acute ischaemic stroke Postgrad. Med. J., March 1, 2001; 77(905): 166 - 171. [Full Text] |
||||
![]() |
P. A. Lapchak, D. F. Chapman, and J. A. Zivin Pharmacological Effects of the Spin Trap Agents N-t-Butyl-Phenylnitrone (PBN) and 2,2,6,6-Tetramethylpiperidine-N-Oxyl (TEMPO) in a Rabbit Thromboembolic Stroke Model : Combination Studies With the Thrombolytic Tissue Plasminogen Activator Stroke, January 1, 2001; 32(1): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Chest, January 1, 2001; 119(1_suppl): 300S - 320S. [Full Text] [PDF] |
||||
![]() |
P. A. Lapchak, D. F. Chapman, J. A. Zivin, and C. Y. Hsu Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)-Induced Hemorrhage After Thromboembolic Stroke Editorial Comment Stroke, December 1, 2000; 31(12): 3034 - 3040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Zivin Thrombolytic stroke therapy: Past, present, and future Neurology, July 1, 1999; 53(1): 14 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Frankel, W. M. Clark, P. D. Lyden, K. P. Madden, J. A. Zivin, M. S. Firstenberg, M. Hommel, C. Cornu, and F. Boutitie Thrombolytic Therapy in Acute Ischemic Stroke N. Engl. J. Med., January 2, 1997; 336(1): 65 - 67. [Full Text] |
||||
![]() |
W. D. Dietrich, L. P. Miller, R. Prado, S. Dewanjee, N. Alexis, M. K. Dewanjee, and H. Gruber Acadesine Reduces Indium-Labeled Platelet Deposition After Photothrombosis of the Common Carotid Artery in Rats Stroke, January 1, 1995; 26(1): 111 - 116. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |